Status:
UNKNOWN
The Effect of Vitamin A on Atherosclerosis
Lead Sponsor:
Tehran University of Medical Sciences
Conditions:
Atherosclerosis
Eligibility:
All Genders
35-70 years
Phase:
PHASE4
Brief Summary
The aim of this study is the comparison between the effects of supplementation with 25000 IU preformed vitamin A (retinyl palmitate) or placebo for 4 months on gene expression of T CD4+ lymphocyte in ...
Detailed Description
Atherosclerosis, the leading cause of death and disability in the world, is considered an inflammatory disease with a complex etiology. The immune system has a prominent role in the formation, develop...
Eligibility Criteria
Inclusion
- • The criteria for enrollment of the patients and control subjects is consecutive patients of both sexes referred to the Division of Cardiology of the one of the Hospitals of Tehran University of Medical Sciences for coronary angiography for investigation of chest pain and/or suspected CAD.
Exclusion
- Patients who have diseases which affect on Th1/Th2 balance such as asthma, active viral infections, and autoimmune diseases, OR
- Patients who have allergy to vitamin A compounds, OR
- Patients who have used vitamin supplements in last 3 months.
Key Trial Info
Start Date :
May 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2011
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT01414972
Start Date
May 1 2010
End Date
November 1 2011
Last Update
August 11 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tehran University of Medical Sciences, School of Public Health
Tehran, Iran